Indivior Pharmaceuticals, Inc. (INDV)
36.18
-0.69
(-1.87%)
USD |
NASDAQ |
Aug 24, 16:00
36.18
0.00 (0.00%)
After-Hours: 20:00
Indivior Pharmaceuticals Total Liabilities (Quarterly) : 1.441B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.441B |
| March 31, 2026 | 1.341B |
| December 31, 2025 | 1.302B |
| September 30, 2025 | 1.623B |
| June 30, 2025 | 1.71B |
| March 31, 2025 | 1.66B |
| December 31, 2024 | 1.659B |
| September 30, 2024 | 1.631B |
| June 30, 2024 | 1.656B |
| March 31, 2024 | 1.443B |
| December 31, 2023 | 1.954B |
| September 30, 2023 | 1.876B |
| June 30, 2023 | 1.614B |
| March 31, 2023 | 1.683B |
| December 31, 2022 | 1.718B |
| September 30, 2022 | 1.444B |
| June 30, 2022 | 1.49B |
| March 31, 2022 | 1.492B |
| December 31, 2021 | 1.629B |
| September 30, 2021 | 1.539B |
| June 30, 2021 | 1.438B |
| March 31, 2021 | 1.447B |
| December 31, 2020 | 1.449B |
| Date | Value |
|---|---|
| September 30, 2020 | 1.467B |
| June 30, 2020 | 1.493B |
| March 31, 2020 | 1.473B |
| December 31, 2019 | 1.443B |
| September 30, 2019 | 1.338B |
| June 30, 2019 | 1.363B |
| March 31, 2019 | 1.472B |
| December 31, 2018 | 1.481B |
| September 30, 2018 | 1.507B |
| June 30, 2018 | 1.625B |
| March 31, 2018 | 1.60B |
| December 31, 2017 | 1.647B |
| September 30, 2017 | 1.441B |
| June 30, 2017 | 1.462B |
| March 31, 2017 | 1.436B |
| December 31, 2016 | 1.504B |
| September 30, 2016 | 1.471B |
| June 30, 2016 | 1.24B |
| March 31, 2016 | 1.253B |
| December 31, 2015 | 1.216B |
| September 30, 2015 | 1.267B |
| June 30, 2015 | 1.292B |
| March 31, 2015 | 1.262B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Supernus Pharmaceuticals, Inc. | 396.88M |
| Liquidia Corp. | 326.80M |
| Corcept Therapeutics, Inc. | 182.93M |
| Amneal Pharmaceuticals, Inc. | 3.659B |
| Prestige Consumer Healthcare, Inc. | 2.652B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.233B |
| Shareholders Equity (Quarterly) | -208.00M |
| Debt to Equity Ratio | -2.447 |
| Current Ratio | 0.8353 |
| Net Debt Paydown Yield | -0.57% |